Wednesday, February 26, 2025 | 06:47 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Clotting cases after vaccination miniscule, but pose definitive risk: Govt

Since the vaccination drive was initiated, only 700 cases --- 9.3 cases per million doses administered --- were reported to be serious in nature, says health ministry

coronavirus, vaccine, vaccination, covid-19
Premium

BS Web Team New Delhi
Bleeding and clotting cases following coronavirus vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the national AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health and Family Welfare said.

"Following the alerts in some countries on post-vaccination “embolic and thrombotic (clotting) events” with AstraZeneca-Oxford vaccine (Covishield in India), a decision was taken to conduct an urgent in-depth analysis of the adverse events in India in the light of the global concerns," the health ministry said on Monday.

However, the government, citing AEFI data, said

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in